Navigation Links
FDA Approves Adcetris to Treat Two Types of Lymphoma
Date:8/19/2011

ness of Adcetris in patients with HL was evaluated in a single clinical trial involving 102 patients. In the single-arm trial, patients were only treated with Adcetris. The study's primary endpoint was objective response rate, the percentage of patients who experienced complete or partial cancer shrinkage or disappearance after treatment. Seventy-three percent of patients achieved either a complete or partial response to the treatment. On average, these patients responded to the therapy for 6.7 months.

The effectiveness of Adcetris in patients with systemic ALCL was evaluated in a single clinical trial in 58 patients. In the single-arm trial, patients were only treated with Adcetris. Similar to the HL trial, the trial's primary endpoint was objective response rate. Of the patients receiving Adcetris for ALCL, 86 percent experienced either a complete or partial response and responded on average for 12.6 months.

The most common side effects experienced with Adcetris were a decrease in infection-fighting white blood cells (neutropenia), nerve damage (peripheral sensory neuropathy), fatigue, nausea, anemia, upper respiratory infection, diarrhea, fever, cough, vomiting, and low blood platelet levels (thrombocytopenia).

Pregnant women should be aware that Adcetris might cause harm to their unborn baby.  

The drug is being approved under the FDA's accelerated approval program, which allows the agency to approve a drug to treat a serious disease based on clinical data showing that the drug has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients. The program is designed to provide patients with earlier access to promising new drugs, but the company will be required to submit additional clinical information after approval to confirm the drug's clinical benefit.

Adcetris is marketed by Seattle Genetics of Bothell, Wash.

For more information:

FDA: Office of Oncology Drug Pr
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Research and Markets has announced the addition ... Report 2014" report to their offering. ... and Chinese Aseptic Packaging Industry Report is a professional ... global Aseptic Packaging industry with a focus on the ... of the industry including definitions, classifications, applications and industry ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p0356852/mHealth-and-Home-Monitoring-–-6th-Edition.html Executive ... services are delivered, leading to better outcomes, decreased ... The market for mHealth solutions is still in ...
(Date:7/30/2014)...  Decision Resources Group finds that ... imaging system market will be significantly driven by ... computed tomography and magnetic resonance imaging with nuclear ... the need for higher-quality imaging to satisfy more ... spur preclinical imaging system sales. Other ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2
(Date:7/30/2014)... CT (PRWEB) July 30, 2014 It is ... Affair proved this to be true as a product ... Conference in Las Vegas this past June. , Lash ... artists and overall success of the eyelash industry through collaboration ... very proud to have supported NEESA ’s event. Lash ...
(Date:7/30/2014)... Recently, Agebc.com, one of the most ... its new line of affordable flower girl dresses ... in several popular styles: sequined ball-gown, scoop neckline, fully ... company’s fresh assortment are: short chiffon dresses with delicate ... of course the classic beautiful colored tulle flower girl ...
(Date:7/30/2014)... University of Adelaide psychology researchers has shed new light ... teens. , School of Psychology PhD student ... students aged 12-18 to better understand their sleep habits, ... were most active (known as their "chronotype"). , The ... Medicine , may have implications for the clinical ...
(Date:7/30/2014)... More accurate tests could be created to diagnose diseases ... injuries, leading to earlier intervention, according to new findings ... involved investigating the components of memory using a combination ... be used to create a diagnostic tool for distinguishing ... or forms of amnesia caused by head trauma. ...
(Date:7/30/2014)... 4DSP’s new CES720 (Compact Embedded System) is ... provide a complete and generic processing platform for data ... in an enclosure measuring five inches per side and ... x86 CPU tightly coupled to a high-performance Xilinx ... VITA 57.1). The Kintex-7 410T FPGA provides a ...
Breaking Medicine News(10 mins):Health News:Lash Affair Launches a New Product as Sponsor of the First U.S. Lash Extension Competition 2Health News:Affordable Flower Girl Dresses Recently Unveiled at Agebc.com 2Health News:Teen insomnia is linked with depression and anxiety 2Health News:Hope for more accurate diagnosis of memory problems 2Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 2Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 3Health News:4DSP Introduces a Compact Platform for UAVs with Embedded Processing and Flexible IO 4
... ET , , Covers Europe, Middle East and ... , , Includes Licensing Option and Development Funding for ... England, June 22 NeurogesX, Inc. (Nasdaq: NGSX ) and ... Pharma Inc. announced today that the companies have entered into an exclusive ...
... ... services company , ... Westminster, Colo. (PRWEB) June 22, 2009 -- Silver Creek Systems®, the pioneer ... today that their DataLens™ System was selected by McKesson Medical-Surgical to automate the processes ...
... , Web Site Features "Anesthesia & Me"(C) Checklist ... Preparation for Surgery , , LifelinetoModernMedicine.com Provides ... , CHICAGO, June 22 Every year, ... of inpatient surgery. To help educate and inform ...
... guided imagery has been steadily gaining in popularity and ... new research demonstrates its efficacy for producing heightened immune ... A new self-help audio recording designed to strengthen natural ... and bacterial illnesses was released this week by Health ...
... Taiwan, June 22 /PRNewswire-Asia/ -- The Healthcare & ... of a Memorandum of,Understanding (MOU) with the Science ... non-profit organization under the National,Applied Research Laboratories in ... for Taiwan,s Science & Technology (S&T) development. , ...
... ... by Esco. The videos can be viewed at: http://us.escoglobal.com/resources/hospital-pharmacy-products/videos.php . , ... Hatboro, PA (PRWEB) June 22, ... education videos for the compounding pharmacy industry. Titled "Pharmacy Isolator Safe Use ...
Cached Medicine News:Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 2Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 3Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 4Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 5Health News:NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM) 6Health News:McKesson Medical-Surgical Selects DataLens System to Automate Product Data Mastering 2Health News:American Society of Anesthesiologists Launches Web Site Focused on Educating and Empowering the Public about Anesthesiology 2Health News:American Society of Anesthesiologists Launches Web Site Focused on Educating and Empowering the Public about Anesthesiology 3Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 2Health News:Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning 3Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 3Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 2Health News:New Compounding Pharmacy Videos Provide Product Information, Teach Safety 3
69" 5 shelves electric rotating display with gunmetal grey frame. Lead time 6-8 weeks....
... impact for the marketing of optical frames ... frames allows your retail area to maximize ... eye-catching displays. The products are shown at ... Removable holders. Variable number of frames displayed ...
A quarter-vision dispensing case or table with a 6" high glass display area and halogen lights. Based on size of case, enjoy either 4, 5.5, 7 or 8 square feet respectively of elegant shelf space for ...
Eye-Kraft is an independent, full-service ophthalmic laboratory. It offers first-quality products, same-day service and overnight delivery with ongoing research and development....
Medicine Products: